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Tau is a cytoskeletal protein that is mainly enriched in
axons where it is thought to regulate microtubule dynam-
ics. Tau is also involved in many diseases referred to as
"tauopathies" which includes Alzheimer's disease (AD).
In AD, tau is redistributed to the somato-dendritic com-
partment and becomes aggregated.
To study the effect of tau proteins (a wild type tau and a
R406W mutation present in cases of Frontotemporal
dementia and parkinsonism linked to chromosome 17,
FTDP-17) in living cells, different PC12 cell lines express-
ing the proteins were created. With the purpose of study-
ing their mobility, the proteins were fused to a
photoactivatable molecule.
The stable lines showed differences in their state of phos-
phorylation as analyzed by western blots, where mutant
tau exhibited a hypophosphorylated state. The develop-
ment of neurites after NGF treatment showed differences
in the kinetics in that mutant-tau-expressing cells devel-
oped processes earlier, which also became longer
throughout time.
Finally, photoactivation experiments revealed that the
mutant tau line shows a higher proportion of stationary
tau proteins over time suggesting a potential mechanism
for the different distribution of mutant proteins or differ-
ently phosphorylated proteins in tauopathies. This find-
ing was not related to an effect on microtubule stability as
could be seen in western blots by analyzing the degree of
tubulin acetylation.
Taken together, the data demonstrate that photoactivata-
ble tau proteins provide a useful tool to analyze dynamic
properties (with a supportive biochemical correlate) in a
living neuronal cell model scenario to help determine the
effects of different tau mutations in neurodegenerative
diseases.
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